GALD vs PPGN: Side-by-Side Comparison
Compare Galderma Group N (GALD) and PolyPeptide Group AG (PPGN) side by side: market cap CHF 43.03B vs CHF 1.59B. Financials, growth and model signals on Bullrun.
| Metric | GALD | PPGN |
|---|---|---|
| Company | Galderma Group N | PolyPeptide Group AG |
| Country / Exchange | Switzerland · SW | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | CHF 43.03B | CHF 1.59B |
| P/E ratio | 88.2 | — |
| Dividend yield | 0.19% | — |
| Valuation model | — | — |
| Revenue (FY2025) | CHF 5.24B | CHF 391.87M |
| Revenue growth YoY | +18.0% | +15.7% |
| Net income | CHF 613.00M | CHF -21.17M |
| Gross margin | 68.9% | 17.0% |
| Diluted EPS | — | -0.64 |